Gland Pharma,6 stocks hit 52-week highs, rally up to 20% in a month

Despite a marginal rise in the Sensex, seven BSE 500 stocks touched fresh 52-week highs, signalling strong bullish momentum. Gland Pharma, Solar Industries, Laurus Labs, and Sun Pharma were among the key gainers, supported by solid monthly performance and sustained investor buying interest.

Gold loan giant Muthoot FinCorp plans Rs 4,000 crore IPO. Check details

Muthoot FinCorp has approved plans to raise up to Rs 4,000 crore via an IPO, aiming to fund expansion in the fast-growing gold loan market. The company, fully owned by its promoter family, plans a fresh issue of shares as strong gold prices and demand boost sector growth prospects.

Market moves driven more by psychology than fundamentals: Samir Arora

Indian stock markets are caught between global worries and strong domestic company profits. Foreign investor activity, oil price swings, and economic news are shaping market mood. Samir Arora of Helios Capital believes current market jitters are more about perception than lasting damage. He notes corporate earnings are exceeding expectations.

Why Samsung shares just surged 7% to save Kospi from a tragic market meltdown

Samsung Electronics shares surged sharply on Monday after the company resumed mediated wage negotiations with its largest labour union, easing fears of a disruptive strike. The rebound helped lift the KOSPI, as Samsung’s heavy index weight amplified the market impact. Investor sentiment improved after political and corporate leaders intervened to calm tensions.

Macro worries cloud markets, but domestic fundamentals offer cushion: Sandip Sabharwal

Market expert Sandip Sabharwal highlights that despite global headwinds like rising crude oil and currency weakness, Indian corporate fundamentals offer stability. He views the Bharti-Prudential deal positively for FDI and sees potential tactical upside in the IT sector, while cautioning about Vodafone Idea’s structural challenges and favoring private banks over PSUs.

Amber Enterprises shares crash 18% after Q4 results. What’s spooking investors?

Amber Enterprises shares plunged almost 18% on Monday. This followed the company’s January-March quarter results. Net profit rose 15% year-on-year to Rs 134 crore. Revenue grew over 10% to Rs 4,148 crore. However, adjusted profit after tax declined significantly due to JV losses. The company anticipates future margin pressure.